Voltaren Emulgel Extra Sterk 2,32% gel

Voltaren is a globally recognized brand specializing in pain management treatments, originally developed in Switzerland by the pharmaceutical company Ciba-Geigy, which later became part of Novartis. The specific product shown, Voltaren Emulgel, is a topical anti-inflammatory gel used to treat muscle and joint pain.

In 2022, the brand became part of Haleon, a major independent consumer healthcare company formed through the demerger of GSK's consumer healthcare business, which had previously merged with Novartis's consumer health portfolio. Today, Haleon is headquartered in the United Kingdom and manages Voltaren's global distribution. Manufacturing occurs in various specialized pharmaceutical facilities across Europe and North America to serve different regional markets.